Development of an Inflatable Haptic Device for Pain Reduction by Social Touch

2021 ◽  
Author(s):  
Youchan Yim ◽  
Fumihide Tanaka
Keyword(s):  
Pain Reduction ◽  
Haptic Device ◽  
Social Touch

Postoperative Pain Reduction in Thoracic Surgery through Multifactorial Treatment Approach

2016 ◽  
Vol 64 (S 01) ◽  
Author(s):  
F. Dörr ◽  
S. Macherey ◽  
M. Heldwein ◽  
S. Stange ◽  
T. Wahlers ◽  
...  
Keyword(s):  
Postoperative Pain ◽  
Thoracic Surgery ◽  
Treatment Approach ◽  
Pain Reduction

Effects of Electrocompression Therapy on Walking Distance and Pain Reduction in Patients with Diabetic Neuropathy

2019 ◽  
Vol 31 (4) ◽  
pp. 345-352
Author(s):  
Arun G. Maiya ◽  
A. Sampath Kumar ◽  
Esha Arora ◽  
Shubha Gundmi ◽  
L. Ramachandra ◽  
...  
Keyword(s):  
Diabetic Neuropathy ◽  
Pain Reduction ◽  
Walking Distance

Gamma knife surgery of the pituitary: new treatment for thalamic pain syndrome

2005 ◽  
Vol 102 (Special_Supplement) ◽  
pp. 38-41 ◽  
Author(s):  
Motohiro Hayashi ◽  
Takaomi Taira ◽  
Taku Ochiai ◽  
Mikhail Chernov ◽  
Yuichi Takasu ◽  
...  
Keyword(s):  
Pituitary Gland ◽  
Diabetes Insipidus ◽  
Gamma Knife ◽  
Pain Syndrome ◽  
Pain Reduction ◽  
Gamma Knife Surgery ◽  
Content Type ◽  
Thalamic Pain Syndrome ◽  
Thalamic Pain ◽  
Fine Print

Object. Although reports in the literature indicate that thalamic pain syndrome can be controlled with chemical hypophysectomy, this procedure is associated with transient diabetes insipidus. It was considered reasonable to attempt gamma knife surgery (GKS) to the pituitary gland to control thalamic pain. Methods. Inclusion criteria in this study were poststroke thalamic pain, failure of all other treatments, intolerance to general anesthetic, and the main complaint of pain and not numbness. Seventeen patients met these criteria and were treated with GKS to the pituitary. The target was the pituitary gland together with the border between the pituitary stalk and the gland. The maximum dose was 140 to 180 Gy. All patients were followed for more than 3 months. Conclusions. An initial significant pain reduction was observed in 13 (76.5%) of 17 patients. Some patients experienced pain reduction within 48 hours of treatment. Persistent pain relief for more than 1 year was observed in five (38.5%) of 13 patients. Rapid recurrence of pain in fewer than 3 months was observed in four (30.8%) of 13 patients. The only complication was transient diabetes insipidus in one patient. It would seem that GKS of the pituitary might have a role to play in thalamic pain arising after a stroke.

(213) Pain Reduction in Cognitively Impaired Cancer Patients Treated with Olanzapine

Pain Medicine ◽  
2001 ◽  
Vol 2 (3) ◽  
pp. 243-244
Author(s):  
Natalia Khojainova ◽  
Juan Santiago-Palma ◽  
Gilbert R. Gonzales
Keyword(s):  
Cancer Patients ◽  
Pain Reduction ◽  
Cognitively Impaired
Sign in / Sign up

Export Citation Format

Share Document